
Company Number
03039521
Next Accounts
Sep 2025
Shareholders
axa france iard sa
Group Structure
View All
Industry
Other business support service activities n.e.c.
+1Registered Address
20 gracechurch street, london, EC3V 0BG
Website
http://securehealth.co.ukPomanda estimates the enterprise value of AXA GLOBAL HEALTHCARE (UK) LIMITED at £86.4m based on a Turnover of £68.8m and 1.26x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AXA GLOBAL HEALTHCARE (UK) LIMITED at £0 based on an EBITDA of £-4.1m and a 11.58x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AXA GLOBAL HEALTHCARE (UK) LIMITED at £13.6m based on Net Assets of £7.2m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Axa Global Healthcare (uk) Limited is a live company located in london, EC3V 0BG with a Companies House number of 03039521. It operates in the non-life insurance sector, SIC Code 65120. Founded in March 1995, it's largest shareholder is axa france iard sa with a 100% stake. Axa Global Healthcare (uk) Limited is a mature, large sized company, Pomanda has estimated its turnover at £68.8m with high growth in recent years.
Pomanda's financial health check has awarded Axa Global Healthcare (Uk) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
3 Weak
Size
annual sales of £68.8m, make it larger than the average company (£3.4m)
£68.8m - Axa Global Healthcare (uk) Limited
£3.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (7.7%)
15% - Axa Global Healthcare (uk) Limited
7.7% - Industry AVG
Production
with a gross margin of 69.1%, this company has a comparable cost of product (69.1%)
69.1% - Axa Global Healthcare (uk) Limited
69.1% - Industry AVG
Profitability
an operating margin of -6.8% make it less profitable than the average company (11.6%)
-6.8% - Axa Global Healthcare (uk) Limited
11.6% - Industry AVG
Employees
with 439 employees, this is above the industry average (26)
439 - Axa Global Healthcare (uk) Limited
26 - Industry AVG
Pay Structure
on an average salary of £71.6k, the company has a higher pay structure (£59.6k)
£71.6k - Axa Global Healthcare (uk) Limited
£59.6k - Industry AVG
Efficiency
resulting in sales per employee of £156.8k, this is equally as efficient (£167.6k)
£156.8k - Axa Global Healthcare (uk) Limited
£167.6k - Industry AVG
Debtor Days
it gets paid by customers after 91 days, this is earlier than average (129 days)
91 days - Axa Global Healthcare (uk) Limited
129 days - Industry AVG
Creditor Days
its suppliers are paid after 719 days, this is slower than average (162 days)
719 days - Axa Global Healthcare (uk) Limited
162 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Axa Global Healthcare (uk) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 40 weeks, this is more cash available to meet short term requirements (20 weeks)
40 weeks - Axa Global Healthcare (uk) Limited
20 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 89.1%, this is a higher level of debt than the average (72%)
89.1% - Axa Global Healthcare (uk) Limited
72% - Industry AVG
Axa Global Healthcare (Uk) Limited's latest turnover from December 2023 is £68.8 million and the company has net assets of £7.2 million. According to their latest financial statements, Axa Global Healthcare (Uk) Limited has 439 employees and maintains cash reserves of £45.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 68,825,000 | 67,014,000 | 62,382,000 | 45,216,000 | 42,308,000 | 40,440,000 | 39,246,000 | 178,000 | 6,963,000 | 7,170,000 | 7,184,000 | 7,184,000 | 7,053,000 | ||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 4,950,000 | 4,438,000 | 4,431,000 | 4,329,000 | 2,905,000 | ||||||||||
Gross Profit | 2,013,000 | 2,732,000 | 2,753,000 | 2,855,000 | 4,148,000 | ||||||||||
Admin Expenses | 5,418,000 | 1,452,000 | 2,463,000 | 2,591,000 | 2,312,000 | 2,786,000 | |||||||||
Operating Profit | -4,694,000 | 1,236,000 | 2,316,000 | -433,000 | -2,409,000 | -2,852,000 | -2,809,000 | -3,049,000 | -5,418,000 | 561,000 | 269,000 | 162,000 | 543,000 | 1,362,000 | |
Interest Payable | 221,000 | 131,000 | 663,000 | 1,000 | 1,000 | 1,000 | 4,000 | 4,000 | |||||||
Interest Receivable | 450,000 | 106,000 | 18,000 | 13,000 | 34,000 | 33,000 | 37,000 | ||||||||
Pre-Tax Profit | -12,507,000 | 1,105,000 | 2,766,000 | -1,096,000 | -2,303,000 | -2,828,000 | -2,958,000 | -3,025,000 | -5,440,000 | 578,000 | 281,000 | 195,000 | 572,000 | 1,395,000 | |
Tax | 788,000 | -73,000 | -1,078,000 | -92,000 | -815,000 | 343,000 | 2,000,000 | 593,000 | 1,094,000 | -144,000 | -112,000 | -89,000 | -189,000 | -426,000 | |
Profit After Tax | -11,719,000 | 1,032,000 | 1,688,000 | -1,188,000 | -3,118,000 | -2,485,000 | -958,000 | -2,432,000 | -4,346,000 | 434,000 | 169,000 | 106,000 | 383,000 | 969,000 | |
Dividends Paid | 4,130,000 | ||||||||||||||
Retained Profit | -11,719,000 | 1,032,000 | 1,688,000 | -1,188,000 | -3,118,000 | -2,485,000 | -958,000 | -2,432,000 | -4,346,000 | 434,000 | 169,000 | -4,024,000 | 383,000 | 969,000 | |
Employee Costs | 31,425,000 | 26,871,000 | 21,954,000 | 20,157,000 | 18,677,000 | 3,472,000 | 3,475,000 | 843,000 | 1,202,000 | 1,710,000 | 1,458,000 | 1,669,000 | |||
Number Of Employees | 439 | 402 | 351 | 345 | 346 | 300 | 295 | 15 | 24 | 45 | 51 | 55 | |||
EBITDA* | -4,110,000 | 1,236,000 | 2,900,000 | 151,000 | -1,825,000 | -2,268,000 | -2,225,000 | -3,049,000 | -5,418,000 | 587,000 | 299,000 | 222,000 | 619,000 | 1,414,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 18,000 | 12,000 | 31,000 | 58,000 | 55,000 | ||||||||||
Intangible Assets | 8,176,000 | 8,760,000 | 9,344,000 | 9,928,000 | 10,512,000 | 11,096,000 | |||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 8,176,000 | 8,760,000 | 9,344,000 | 9,928,000 | 10,512,000 | 11,096,000 | 18,000 | 12,000 | 31,000 | 58,000 | 55,000 | ||||
Stock & work in progress | |||||||||||||||
Trade Debtors | 17,234,000 | 24,962,000 | 21,856,000 | 26,526,000 | 4,271,000 | 121,000 | 1,000 | 44,000 | 28,000 | 35,000 | 32,000 | ||||
Group Debtors | 993,000 | 2,456,000 | 1,000 | 4,482,000 | 149,000 | 225,000 | 165,000 | 160,000 | 172,000 | ||||||
Misc Debtors | 2,320,000 | 441,000 | 297,000 | 927,000 | 7,516,000 | 6,993,000 | 7,699,000 | 1,904,000 | 1,094,000 | 258,000 | 176,000 | 179,000 | 95,000 | 120,000 | |
Cash | 45,739,000 | 42,561,000 | 38,216,000 | 28,984,000 | 20,251,000 | 7,409,000 | 4,701,000 | 18,398,000 | 3,774,000 | 3,263,000 | 2,565,000 | 6,444,000 | 6,109,000 | ||
misc current assets | 8,000 | 7,000 | 58,000 | 62,000 | 57,000 | 45,000 | 43,000 | ||||||||
total current assets | 66,286,000 | 67,964,000 | 60,369,000 | 58,893,000 | 32,038,000 | 14,531,000 | 12,408,000 | 20,302,000 | 5,576,000 | 4,240,000 | 3,770,000 | 2,994,000 | 6,779,000 | 6,476,000 | |
total assets | 66,286,000 | 76,140,000 | 69,129,000 | 68,237,000 | 41,966,000 | 25,043,000 | 23,504,000 | 20,302,000 | 5,576,000 | 4,258,000 | 3,782,000 | 3,025,000 | 6,837,000 | 6,531,000 | |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 41,849,000 | 36,736,000 | 35,367,000 | 40,097,000 | 18,573,000 | 279,000 | 745,000 | 520,000 | 522,000 | 591,000 | 472,000 | ||||
Group/Directors Accounts | 3,845,000 | 3,634,000 | 4,763,000 | 359,000 | 60,000 | 1,615,000 | 419,000 | 2,472,000 | 808,000 | 804,000 | 473,000 | 152,000 | 1,000 | ||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 13,335,000 | 16,698,000 | 11,657,000 | 12,438,000 | 6,128,000 | 4,611,000 | 4,814,000 | 1,963,000 | 340,000 | 527,000 | 268,000 | 308,000 | 655,000 | ||
total current liabilities | 59,029,000 | 57,068,000 | 51,787,000 | 52,535,000 | 25,060,000 | 4,950,000 | 6,429,000 | 2,382,000 | 2,472,000 | 1,893,000 | 1,851,000 | 1,263,000 | 1,051,000 | 1,128,000 | |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | 30,000 | 54,000 | |||||||||||||
total long term liabilities | 30,000 | 54,000 | |||||||||||||
total liabilities | 59,059,000 | 57,122,000 | 51,787,000 | 52,535,000 | 25,060,000 | 4,950,000 | 6,429,000 | 2,382,000 | 2,472,000 | 1,893,000 | 1,851,000 | 1,263,000 | 1,051,000 | 1,128,000 | |
net assets | 7,227,000 | 19,018,000 | 17,342,000 | 15,702,000 | 16,906,000 | 20,093,000 | 17,075,000 | 17,920,000 | 3,104,000 | 2,365,000 | 1,931,000 | 1,762,000 | 5,786,000 | 5,403,000 | |
total shareholders funds | 7,227,000 | 19,018,000 | 17,342,000 | 15,702,000 | 16,906,000 | 20,093,000 | 17,075,000 | 17,920,000 | 3,104,000 | 2,365,000 | 1,931,000 | 1,762,000 | 5,786,000 | 5,403,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -4,694,000 | 1,236,000 | 2,316,000 | -433,000 | -2,409,000 | -2,852,000 | -2,809,000 | -3,049,000 | -5,418,000 | 561,000 | 269,000 | 162,000 | 543,000 | 1,362,000 | |
Depreciation | 26,000 | 30,000 | 60,000 | 76,000 | 52,000 | ||||||||||
Amortisation | 584,000 | 584,000 | 584,000 | 584,000 | 584,000 | 584,000 | |||||||||
Tax | 788,000 | -73,000 | -1,078,000 | -92,000 | -815,000 | 343,000 | 2,000,000 | 593,000 | 1,094,000 | -144,000 | -112,000 | -89,000 | -189,000 | -426,000 | |
Stock | |||||||||||||||
Debtors | -4,856,000 | 3,250,000 | -7,756,000 | 18,122,000 | 4,673,000 | -586,000 | 5,796,000 | -3,672,000 | 5,576,000 | -408,000 | -37,000 | 73,000 | 82,000 | -34,000 | 324,000 |
Creditors | 5,113,000 | 1,369,000 | -4,730,000 | 21,524,000 | 18,294,000 | 279,000 | -745,000 | 225,000 | -2,000 | -69,000 | 119,000 | 472,000 | |||
Accruals and Deferred Income | -3,363,000 | 5,041,000 | -781,000 | 6,310,000 | 1,517,000 | -203,000 | 2,851,000 | 1,963,000 | -340,000 | -187,000 | 259,000 | -40,000 | -347,000 | 655,000 | |
Deferred Taxes & Provisions | -24,000 | 54,000 | |||||||||||||
Cash flow from operations | 3,260,000 | 4,377,000 | 4,067,000 | 9,771,000 | 12,498,000 | -1,263,000 | -3,170,000 | 3,179,000 | -9,900,000 | 518,000 | 371,000 | -58,000 | 236,000 | 1,791,000 | |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 211,000 | -1,129,000 | 4,763,000 | -359,000 | 299,000 | -1,555,000 | 1,196,000 | -2,053,000 | 2,472,000 | -808,000 | 4,000 | 331,000 | 321,000 | 151,000 | 1,000 |
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -221,000 | -131,000 | 450,000 | -663,000 | 106,000 | 17,000 | 12,000 | 33,000 | 29,000 | 33,000 | |||||
cash flow from financing | -82,000 | -616,000 | 5,165,000 | -1,038,000 | 336,000 | 3,948,000 | 1,309,000 | 15,195,000 | 9,922,000 | 21,000 | 343,000 | 354,000 | 180,000 | 4,468,000 | |
cash and cash equivalents | |||||||||||||||
cash | 3,178,000 | 4,345,000 | 9,232,000 | 8,733,000 | 12,842,000 | 2,708,000 | -13,697,000 | 18,398,000 | -3,774,000 | 511,000 | 698,000 | -3,879,000 | 335,000 | 6,109,000 | |
overdraft | |||||||||||||||
change in cash | 3,178,000 | 4,345,000 | 9,232,000 | 8,733,000 | 12,842,000 | 2,708,000 | -13,697,000 | 18,398,000 | -3,774,000 | 511,000 | 698,000 | -3,879,000 | 335,000 | 6,109,000 |
Perform a competitor analysis for axa global healthcare (uk) limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other large companies, companies in EC3V area or any other competitors across 12 key performance metrics.
AXA GLOBAL HEALTHCARE (UK) LIMITED group structure
Axa Global Healthcare (Uk) Limited has no subsidiary companies.
Ultimate parent company
AXA FRANCE IARD SA
#0164296
1 parent
AXA GLOBAL HEALTHCARE (UK) LIMITED
03039521
Axa Global Healthcare (Uk) Limited currently has 6 directors. The longest serving directors include Mrs Charlotte Roux (Jan 2017) and Mr Andrew Davies (Jun 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Charlotte Roux | United Kingdom | 49 years | Jan 2017 | - | Director |
Mr Andrew Davies | United Kingdom | 58 years | Jun 2017 | - | Director |
Mr Noel Richardson | United Kingdom | 60 years | Jan 2021 | - | Director |
Mr Xavier Lestrade | United Kingdom | 53 years | Jun 2022 | - | Director |
Mr Ian Johnson | 63 years | Jul 2023 | - | Director | |
Dr Nils Reich | United Kingdom | 44 years | Nov 2023 | - | Director |
P&L
December 2023turnover
68.8m
+3%
operating profit
-4.7m
-480%
gross margin
69.2%
-0.07%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
7.2m
-0.62%
total assets
66.3m
-0.13%
cash
45.7m
+0.07%
net assets
Total assets minus all liabilities
company number
03039521
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
65120 - Non-life insurance
incorporation date
March 1995
age
30
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
axa global protect limited (December 2017)
securehealth limited (December 2014)
accountant
-
auditor
KPMG LLP
address
20 gracechurch street, london, EC3V 0BG
Bank
HSBC BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to axa global healthcare (uk) limited. Currently there are 0 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AXA GLOBAL HEALTHCARE (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|